SEC Form 4 · accession 0001209191-18-044387
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J William Morrow
Officer — SVP - Finance and Treasurer
Period of report
Jul 26, 2018
Accepted (ET)
Jul 30, 2018 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 26, 2018 | M | 3,125 | $17.33 | A | 12,459 | D | |
| Common StockF2 | Jul 26, 2018 | S | 3,125 | $119.81 | D | 9,334 | D | |
| Common StockF2 | Jul 26, 2018 | M | 3,750 | $22.95 | A | 13,084 | D | |
| Common StockF2 | Jul 26, 2018 | F | 1,898 | $124.30 | D | 11,186 | D | |
| Common StockF2 | Jul 30, 2018 | S | 1,852 | $124.40 | D | 9,334 | D | |
| Common Stock | holding | — | — | — | 1,809 | I | By Trust (Spouse, Trustee) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $17.33 | Jul 26, 2018 | M | 3,125 | D | Nov 2, 2015 | Nov 2, 2021 | Common Stock | 3,125 | 0 | D |
| Stock Appreciation RightF3 | $22.95 | Jul 26, 2018 | M | 1,875 | D | — | Feb 8, 2022 | Common Stock | 1,875 | 0 | D |
| Stock Appreciation RightF4 | $22.95 | Jul 26, 2018 | M | 1,875 | D | — | Feb 8, 2022 | Common Stock | 1,875 | 0 | D |
Explanation of responses
- F1The exercise of stock appreciation rights, option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2Includes 860.2342 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
- F3The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.
- F4The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.